Blood analysis method, blood analysis device and storage medium containing executable program
By mixing the blood sample with the reagent for coagulation time measurement in the coagulation analysis device, optical information is obtained to infer the number of platelets, the problem of the number of platelets in plasma samples affecting the measurement results is solved, and the accuracy control of the measurement results is achieved.
Patent Information
- Application Number
- CN201910329094.X
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Priority Date
- 2018-04-26
- Filing Date
- 2019-04-23
- Publication Date
- 2024-11-12
- Estimated Expiration
- 2039-04-23
AI Technical Summary
In the existing coagulation analysis device, the number of platelets in the plasma sample supplied may not be less than 10,000/μL, which affects the measurement results, and the user's centrifugal separation process may not necessarily meet the preferred conditions, resulting in the impact of the accuracy of the measurement results.
By mixing the blood sample with the reagent for coagulation time measurement, optical information changing with time is obtained, information related to coagulation time and platelet count information is obtained based on the optical information, and platelet count is inferred by using the changes in optical information, and then determining whether additional processing or adjustment is needed. Determination results.
It can accurately grasp the impact of platelet number on the measurement results, ensure the accuracy of the measurement results, and avoid inappropriate measurement results caused by excessive platelet number.
Smart Images

Figure CN110411958B_ABST
Abstract
Description
Technical Field
[0001] The invention relates to a blood analysis method, a blood analysis device and a storage medium containing an executable program. Background Art
[0002] Patent Document 1 discloses a coagulation analysis device that performs analysis related to the coagulation function of blood by irradiating a measurement sample prepared by adding a reagent to a plasma sample with light and analyzing the obtained transmitted light.
[0003] Prior art literature
[0004] Patent Literature
[0005] Patent document 1: Japanese Patent Application Publication No. 2014-173904. Summary of the invention
[0006] Technical problem to be solved by the invention
[0007] The plasma sample supplied to the above-mentioned coagulation analysis device is a plasma sample obtained by centrifugation separation of a whole blood sample. Here, the "Consensus on Coagulation Test Sample Processing" in the Journal of the Japanese Society of Hematology, Vol. 17, No. 2 states that in order to suppress the influence on the measurement results, the number of residual platelets in the plasma sample is preferably less than 10,000 / μL, and that centrifugation is preferably performed at 1500 g or more for more than 15 minutes.
[0008] However, the centrifugation performed by the user may not be properly performed under the above conditions, and the number of platelets in the plasma sample may be large depending on the patient's condition. Therefore, the number of platelets remaining in the plasma sample supplied to the device may not be less than the above number. Based on the above situation, practitioners hope to understand the influence of the number of platelets on the measurement results in the coagulation analysis device.
[0009] Technical means to solve technical problems
[0010] A first technical solution of the present invention relates to a blood analysis method. In the blood analysis method of the technical solution, after mixing a blood sample and a reagent for measuring a coagulation time, optical information that changes over time is obtained from the mixed solution of the blood sample and the reagent, and information related to the coagulation time and information based on the number of platelets in the blood sample are obtained based on the obtained optical information.
[0011] The inventors have discovered that the changes in optical information vary depending on the number of platelets in the blood sample. In addition, based on this insight, the inventors have discovered that the number of platelets in the blood sample can be inferred based on the optical information. Therefore, according to the blood analysis method involved in the present technical solution, information based on the number of platelets in the blood sample can be obtained through the above steps. The operator can understand the influence of the number of platelets on the measurement results by referring to this information. In addition, information related to the clotting time refers to information obtained in the coagulation test that is usually performed, such as the clotting time, the concentration obtained based on the clotting time, etc. According to the blood analysis method involved in the present technical solution, information related to the clotting time can be obtained while also obtaining information based on the number of platelets.
[0012] In the blood analysis method involved in the technical solution, information based on the number of platelets in the blood sample is obtained based on the optical information of the end stage of the coagulation reaction of the blood sample in the acquired optical information. The inventors have found that the change in the optical information at the end stage of the coagulation reaction varies depending on the number of platelets in the blood sample. Therefore, information based on the number of platelets in the blood sample can be more effectively obtained based on the optical information at the end stage of the coagulation reaction.
[0013] In the blood analysis method involved in the technical solution, the coagulation end point is detected from the acquired optical information, and information based on the number of platelets in the blood sample is acquired based on the optical information in a certain time range including the time point after the coagulation end point. The inventors have found that the change of the optical information in a certain time range including the time point after the coagulation end point will reflect the number of platelets in the blood sample. Therefore, information based on the number of platelets in the blood sample can be more effectively acquired based on the optical information in a certain time range.
[0014] In the blood analysis method involved in the technical solution, the information based on the number of platelets in the blood sample includes the information related to the number of platelets or the necessity of additional processing of the blood sample. After obtaining the number of platelets as information based on the number of platelets, the operator can grasp the degree to which the blood sample contains platelets. The additional processing includes, for example, re-acquisition of the blood sample, re-centrifugation of the blood sample, etc. After obtaining the information related to the necessity of additional processing as information based on the number of platelets, the operator can determine whether it is necessary to re-acquire a blood sample in an appropriate state.
[0015] In the blood analysis method involved in the technical solution, optical information is obtained based on the first measurement related to the coagulation time measurement, and information based on the number of platelets in the blood sample includes relevant information on the influence on the second measurement different from the first measurement. When the number of platelets in the blood sample is large, sometimes the result of the first measurement is appropriate but the result of the second measurement is inappropriate. In this case, if the relevant information on the influence on the second measurement is obtained as information based on the number of platelets, the operator can judge whether the result of the second measurement is appropriate.
[0016] In the blood analysis method involved in the present technical solution, an index value representing the change of optical information is obtained based on the optical information within a certain time range, and information based on the number of platelets in the blood sample is obtained based on the index value.
[0017] In this case, the index value is the change speed or change amount of the optical information within a certain time range, so that the change of the optical information within a certain time range can be easily grasped.
[0018] At this time, the change speed or change amount is acquired based on the optical information of the start point and the end point of a certain time range.
[0019] In the blood analysis method involved in the technical solution, the information based on the level of the number of platelets in the blood sample is obtained as the information based on the number of platelets in the blood sample by comparing the index value with one or more pre-set first reference values. The index value reflects optical information within a certain time range and changes with the number of platelets in the blood sample. Therefore, the operator can determine whether the number of platelets in the blood sample exceeds the reference value by referring to the information based on the level of the number of platelets in the blood sample.
[0020] In the blood analysis method involved in the technical solution, the platelet count in the blood sample is obtained based on the index value as information based on the platelet count in the blood sample. In this way, since the platelet count in the blood sample can be obtained, the operator can directly determine the influence of the platelet count on the measurement result.
[0021] At this time, the number of platelets in the blood sample is acquired from the index value using information indicating the relationship between the index value and the number of platelets.
[0022] In the blood analysis method involved in the technical solution, by comparing the number of platelets in the blood sample with one or more pre-set second reference values, information based on the level of the number of platelets in the blood sample is further obtained as information based on the number of platelets in the blood sample. When one second reference value is used, the second reference value is, for example, 10,000 / μL. When three second reference values are used, the three second reference values are, for example, 10,000 / μL, 30,000 / μL, and 50,000 / μL. The operator can determine whether the number of platelets in the blood sample exceeds each reference value by referring to the information based on the level of the number of platelets in the blood sample.
[0023] In the blood analysis method involved in the technical solution, information indicating the existence of a measurement item affected by platelets in the blood sample or related information on the necessity of additional processing of the blood sample is obtained based on the number of platelets in the blood sample as information based on the number of platelets in the blood sample. By using the number of platelets in the blood sample, information indicating the existence of a measurement item affected by platelets or related information on the necessity of additional processing can be smoothly obtained.
[0024] In the blood analysis method according to the present technical solution, information based on the number of platelets in the blood sample is displayed on the display unit (33), so that the operator can visually grasp the information based on the number of platelets in the blood sample.
[0025] In the blood analysis method of the present technical solution, optical information is obtained in the step of measuring the coagulation time of the blood sample. Thus, information based on the number of platelets in the blood sample can be obtained based on the step of measuring the coagulation time of the blood sample, and the coagulation time can also be calculated in this step.
[0026] In this case, the coagulation end point is the end point of the time range for calculating the coagulation time of the blood sample.
[0027] In the blood analysis method involved in the technical solution, the starting point of the certain time range is set to be after the coagulation end point.
[0028] In the blood analysis method involved in the present technical solution, the length of the certain time range is not less than 5 seconds and not more than 10 seconds.
[0029] In the blood analysis method involved in the present technical solution, the blood sample is plasma.
[0030] At this point, the whole blood sample was centrifuged to obtain plasma.
[0031] In the blood analysis method according to the present aspect, the optical information is the intensity of transmitted light or scattered light detected by irradiating the blood sample with light, or the absorbance calculated from the intensity of transmitted light or scattered light.
[0032] In the blood analysis method of the present technical solution, the reagent is a prothrombin time measurement reagent or a fibrinogen measurement reagent. According to the inventor's verification, the use of the prothrombin time measurement reagent or the fibrinogen measurement reagent can obtain information based on the number of platelets in the blood sample based on optical information within a certain time range.
[0033] In the blood analysis method according to the present technical solution, when it is determined from information based on the number of platelets in the blood sample that additional processing of the blood sample is necessary, the blood sample is obtained again. This enables smooth and appropriate inspection.
[0034] In the blood analysis method according to the present technical solution, optical information is acquired based on the first measurement related to the coagulation time measurement, and a second measurement different from the first measurement is performed when information based on the number of platelets in the blood sample is less than a certain value. In this way, the second measurement is performed only when the number of platelets is judged to be small according to the first measurement, so the second measurement can be performed appropriately.
[0035] In the blood analysis method involved in the technical solution, optical information is obtained based on the first measurement related to the clotting time measurement, and when the information based on the number of platelets in the blood sample is above a certain value, at least one item selected from the group consisting of the following items is executed: not performing a second measurement different from the first measurement, providing information for indicating an influence on the second measurement, and providing relevant information on the necessity of additional processing of the blood sample before the second measurement. If the second measurement is not performed in this way, it is possible to prevent an inappropriate blood sample with a large number of platelets from being subjected to the second measurement. In addition, if information indicating an influence on the second measurement is provided, the operator can understand the influence on the second measurement. In addition, if relevant information on the necessity of additional processing of the blood sample before the second measurement is provided, the operator can understand the necessity of additional processing.
[0036] A second technical solution of the present invention relates to a blood analysis device. The blood analysis device (10) involved in this technical solution comprises: a measuring unit (22) for irradiating light to a mixed solution formed by mixing a blood sample and a reagent for measuring a coagulation time, and detecting light generated from the mixed solution; and a processing unit (31) for processing the detection result of the measuring unit (22). After the blood sample and the reagent for measuring a coagulation time are mixed, the processing unit (31) obtains optical information that changes with time from the mixed solution of the blood sample and the reagent, and obtains information related to the coagulation time and information based on the number of platelets in the blood sample based on the obtained optical information.
[0037] The blood analyzer according to this technical aspect has the same technical effects as the first technical aspect.
[0038] The blood analysis device (10) involved in the technical solution can be designed such that the processing unit (31) obtains information based on the number of platelets in the blood sample based on optical information of the end stage of the coagulation reaction of the blood sample in the obtained optical information.
[0039] The blood analysis device (10) involved in the present technical solution can be designed as follows: the processing unit (31) detects the coagulation end point from the acquired optical information, and acquires information based on the number of platelets in the blood sample based on the optical information within a certain time range including the time point after the coagulation end point.
[0040] In the blood analysis device (10) according to the present technical solution, the information based on the number of platelets in the blood sample includes information related to the number of platelets or the necessity of additional processing of the blood sample.
[0041] In the blood analysis device (10) according to the present technical solution, the processing unit (31) acquires optical information based on a first measurement related to the coagulation time measurement, and the information based on the number of platelets in the blood sample includes information related to the influence on a second measurement different from the first measurement.
[0042] The blood analysis device (10) involved in the technical solution can be designed as follows: the processing unit (31) obtains an index value representing the change of optical information based on the optical information within a certain time range, and obtains information based on the number of platelets in the blood sample based on the index value.
[0043] In this case, the index value is the change speed or change amount of the optical information within a certain time range.
[0044] At this time, it can be designed that: the processing unit (31) obtains the change speed or change amount based on the optical information of the starting point and the end point of a certain time range.
[0045] The blood analysis device (10) involved in the present technical solution can be designed such that the processing unit (31) obtains information based on the level of platelet count in the blood sample as information based on the platelet count in the blood sample by comparing the index value with one or more pre-set first reference values.
[0046] The blood analysis device (10) involved in the present technical solution can be designed such that: the processing unit (31) obtains the number of platelets in the blood sample based on the index value as information based on the number of platelets in the blood sample.
[0047] In this case, the processing unit (31) may be designed so as to obtain the number of platelets in the blood sample from the index value using information indicating the relationship between the index value and the number of platelets.
[0048] The blood analysis device (10) involved in the present technical solution can be designed as follows: the processing unit (31) compares the number of platelets in the blood sample with one or more pre-set second reference values to further obtain information based on the level of the number of platelets in the blood sample as information based on the number of platelets in the blood sample.
[0049] The blood analysis device (10) involved in the present technical solution can be designed as follows: the processing unit (31) obtains information for indicating the existence of measurement items affected by platelets in the blood sample or related information on the necessity of additional processing of the blood sample based on the number of platelets in the blood sample.
[0050] The blood analysis device (10) involved in the present technical solution can be designed to include a display unit (33), and the processing unit (31) displays information based on the number of platelets in the blood sample on the display unit (33).
[0051] The blood analysis device (10) involved in the technical solution can be designed such that: the processing unit (31) obtains optical information in the step of measuring the coagulation time of the blood sample.
[0052] At this time, the coagulation end point is the end point of the time range used to calculate the coagulation time of the blood sample.
[0053] The blood analysis device (10) involved in the technical solution can be designed so that: the processing unit (31) sets the starting point of a certain time range to after the coagulation end point.
[0054] The blood analysis device (10) involved in the technical solution can be designed such that the length of the certain time range is set to be not less than 5 seconds and not more than 10 seconds.
[0055] In the blood analysis device (10) involved in the technical solution, the blood sample is plasma.
[0056] At this point, the whole blood sample was centrifuged to obtain plasma.
[0057] In the blood analyzer (10) according to the present technical solution, the optical information is the intensity of transmitted light or scattered light detected by irradiating light onto the blood sample, or the absorbance calculated from the intensity of transmitted light or scattered light.
[0058] In the blood analysis device (10) according to the present technical solution, the reagent is a reagent for measuring prothrombin time or a reagent for measuring fibrinogen.
[0059] The blood analysis device (10) involved in the present technical solution can be designed as follows: the measuring unit (22) includes an irradiation unit (22a) for irradiating light to the mixed liquid, and a detection unit (22b) for detecting light generated from the mixed liquid, and the processing unit (31) obtains optical information based on a detection signal output from the detection unit (22b).
[0060] In this case, the design may be such that the detection unit (22b) detects light that is transmitted through the mixed liquid among the light irradiated onto the mixed liquid.
[0061] The blood analysis device (10) involved in the present technical solution can be designed as follows: the processing unit (31) obtains optical information based on a first measurement related to the coagulation time measurement, and performs a second measurement different from the first measurement when information based on the number of platelets in the blood sample is less than a certain value.
[0062] The blood analysis device (10) involved in the technical solution can be designed as follows: the processing unit (31) obtains optical information based on a first measurement related to the coagulation time measurement, and when the information based on the number of platelets in the blood sample is above a certain value, executes at least one item selected from the group consisting of the following items: not performing a second measurement different from the first measurement, providing information indicating an impact on the second measurement, and providing relevant information on the necessity of additional processing of the blood sample before the second measurement.
[0063] A third technical solution of the present invention relates to a storage medium containing an executable program, wherein the program in the storage medium causes a computer to execute a process for blood analysis. The program (32a) in the storage medium containing an executable program according to the technical solution includes the following process: after a blood sample and a reagent for measuring a coagulation time are mixed, optical information that changes with time is obtained from a mixed solution of the blood sample and the reagent, and information related to the coagulation time and information based on the number of platelets in the blood sample are obtained based on the obtained optical information.
[0064] The program in the storage medium containing the executable program involved in this technical solution has the same technical effect as the first technical solution.
[0065] The program (32a) in the storage medium containing the executable program involved in the present technical solution can be designed to obtain information based on the number of platelets in the blood sample based on the optical information of the end stage of the coagulation reaction of the blood sample in the acquired optical information.
[0066] The program (32a) in the storage medium containing the executable program involved in the technical solution can be designed as follows: detecting the coagulation end point from the acquired optical information, and acquiring information based on the number of platelets in the blood sample based on the optical information within a certain time range including the time point after the coagulation end point.
[0067] In the program (32a) in the storage medium containing an executable program according to the present technical solution, the information based on the number of platelets in the blood sample includes information related to the number of platelets or the necessity of additional processing of the blood sample.
[0068] In the program (32a) in the storage medium containing an executable program according to the technical solution, information based on the number of platelets in the blood sample includes information related to the influence on a second measurement, and the second measurement is different from a first measurement related to the coagulation time measurement for obtaining optical information.
[0069] The program (32a) in the storage medium containing the executable program involved in the present technical solution can be designed as follows: optical information is obtained based on a first measurement related to the coagulation time measurement, and a second measurement different from the first measurement is performed when information based on the number of platelets in the blood sample is less than a certain value.
[0070] The program (32a) in the storage medium containing the executable program involved in the present technical solution can be designed as follows: obtaining optical information based on a first measurement related to the coagulation time measurement, and when the information based on the number of platelets in the blood sample is above a certain value, executing at least one of the following group selections: not performing a second measurement different from the first measurement, providing information indicating the impact on the second measurement, and providing relevant information on the necessity of additional processing of the blood sample before the second measurement.
[0071] Effects of the Invention
[0072] According to the present invention, the influence of platelets on the measurement results can be understood. BRIEF DESCRIPTION OF THE DRAWINGS
[0073] Figure 1 is a flowchart showing the outline of the blood analysis method according to the first embodiment;
[0074] Figure 2 is a block diagram showing the structure of a blood analyzer according to an overview of the first embodiment;
[0075] Figure 3 is a flowchart showing the blood analysis method involved in embodiment 1;
[0076] Figure 4 is a schematic top view of the structure of the measuring device involved in embodiment 1;
[0077] Figure 5 1 is a diagram for explaining acquisition of coagulation time by a processing unit of the control device according to the first embodiment;
[0078] Figure 6 (a) is a diagram for explaining a step of acquiring a coagulation end point according to the first embodiment; Figure 6(b) and (c) are diagrams for explaining the steps of obtaining the coagulation end point according to the modification example;
[0079] Figure 7 is a flowchart showing a process of acquiring information based on the platelet count according to the first embodiment;
[0080] Figure 8 (a) is a diagram showing an index value acquisition interval according to Embodiment 1; Figure 8 (b) to (d) are diagrams showing the index value acquisition intervals involved in the modification examples;
[0081] Fig. 9 (a) is a graph showing the correlation between the slope and the platelet count according to Embodiment 1; Fig. 9 (b) is a table showing the correlation between the slope and the platelet count according to Embodiment 1;
[0082] Fig.10 is a schematic diagram of a structure of an interface displayed on a display unit according to Embodiment 1;
[0083] Fig.11 is a schematic diagram of a structure of an interface displayed on a display unit according to Embodiment 1;
[0084] Fig.12 is a schematic diagram of a structure of an interface displayed on a display unit according to Embodiment 1;
[0085] Fig.13 is a flowchart showing the inspection steps performed by the operator involved in the first embodiment;
[0086] Fig.14 (a) to (g) are diagrams showing solidification curves obtained in the verification according to Embodiment 1;
[0087] Fig.15 (a) to (g) are diagrams showing solidification curves obtained in the verification according to Embodiment 1;
[0088] Fig.16 (a) to (g) are diagrams showing solidification curves obtained in the verification according to Embodiment 1;
[0089] Fig.17 (a) to (c) are graphs showing the verification results of the slope according to the platelet count according to the first embodiment;
[0090] Fig.18 (a) to (g) are diagrams showing solidification curves obtained in the verification according to the modification example;
[0091] Fig.19is a flowchart showing a process for acquiring information based on the platelet count according to the second embodiment;
[0092] Fig. 20 This is a flowchart showing the blood analysis method involved in the third embodiment. DETAILED DESCRIPTION
[0093] <Implementation method 1>
[0094] Reference Figure 1 and Figure 2 The outline of Implementation Example 1 will be described.
[0095] Figure 1 The process shown in the flowchart is to perform measurement in the coagulation analysis process and obtain information based on the platelet count using optical information obtained in the measurement. Figure 1 Processing by Figure 2 The blood analysis device 10 shown performs.
[0096] like Figure 2 As shown, the blood analyzer 10 includes a measuring device 20 and a control device 30. The blood analyzer 10 can irradiate a blood sample prepared by adding a reagent to a blood sample with light, and analyze the obtained transmitted light by a coagulation method, a synthetic matrix method, an immunoturbidimetry method, and an agglutination method to perform coagulation function-related analysis of the blood sample and obtain measurement results for a plurality of measurement items.
[0097] The measuring device 20 includes a preparation unit 21 and a measuring unit 22. The preparation unit 21 dispenses a blood sample from a sample container and heats the dispensed blood sample, and then adds a reagent to the heated blood sample to prepare a blood sample. The measuring unit 22 includes an irradiation unit 22a, a detection unit 22b, and a signal processing unit 22c. The irradiation unit 22a irradiates light to the blood sample prepared in the preparation unit 21. The irradiation unit 22a is, for example, a halogen lamp or an LED. The detection unit 22b receives the transmitted light that transmits the blood sample among the light irradiated by the irradiation unit 22a. The detection unit 22b is, for example, a photodiode or an avalanche photodiode (APD). In addition, the detection unit 22b is not limited to receiving the transmitted light from the blood sample, but may also receive scattered light scattered by the blood sample.
[0098] As the coagulation reaction of the blood sample proceeds, the turbidity of the blood sample increases, and as the turbidity increases, the amount of light transmitted from the blood sample decreases. The detection unit 22b detects the blood coagulation process by the change in the transmitted light. At this time, as the coagulation reaction of the blood sample proceeds, generally the amount of light received by the detection unit 22b decreases. In addition, when the detection unit 22b receives scattered light, as the coagulation reaction of the blood sample proceeds, generally the amount of light received by the detection unit 22b increases.
[0099] The signal processing unit 22c converts the detection signal output from the detection unit 22b into digital data through an AD converter and sends it to the control device 30 as measurement data. The measurement data sent to the control device 30 is data that changes with the passage of time during the detection period from the start of detection by the detection unit 22b to the end of detection by the detection unit 22b. The measurement data is data obtained by detecting the coagulation process of the blood sample in the form of changes in the intensity of the transmitted light over time, and is coagulation curve data. For example, the sampling time interval of the coagulation curve data is 0.1 seconds. The time from the start of detection to the end of detection is, for example, at most 1 hour.
[0100] The control device 30 includes a processing unit 31, a storage unit 32, a display unit 33, and an input unit 34. The processing unit 31 is, for example, a CPU. The storage unit 32 is, for example, a RAM, a ROM, a hard disk, etc. The storage unit 32 stores a computer program 32a for the processing unit 31 to execute.
[0101] The processing unit 31 processes the detection result of the measuring unit 22. Specifically, the processing unit 31 obtains the measurement data sent from the measuring device 20 as optical information, and stores the obtained optical information in the storage unit 32. As described above, the optical information is data indicating the change of the intensity of the transmitted light over time. In addition, if the measurement data is obtained by detecting the coagulation process of the blood sample in the form of the change of the intensity of the scattered light over time, the optical information is data indicating the change of the intensity of the scattered light over time. In addition, it can also be designed that the processing unit 31 calculates the absorbance based on the measurement data sent from the measuring device 20, and obtains the calculated absorbance as optical information.
[0102] The display unit 33 is, for example, a liquid crystal display. The input unit 34 is a mouse and a keyboard. In addition, the display unit 33 and the input unit 34 may also be integrated like a touch screen display.
[0103] return Figure 1 In step S1, the measuring device 20 mixes the blood sample and the reagent for measuring the coagulation time and performs the measurement. The measurement data obtained by the measurement will be sent to the control device 30. In step S2, the processing unit 31 of the control device 30 obtains optical information. In step S3, the processing unit 31 obtains information related to the coagulation time based on the optical information obtained in step S2. Information related to the coagulation time refers to information obtained in a coagulation test that is usually performed, such as the coagulation time, the concentration obtained based on the coagulation time, etc. In step S4, the processing unit 31 obtains information based on the number of platelets in the blood sample based on the optical information obtained in step S2.
[0104] The inventors conducted various tests and found that the change in optical information varies depending on the number of platelets in the blood sample. In addition, based on this insight, the inventors found that the number of platelets in the blood sample can be inferred based on the optical information. Figure 1 The processing shown can obtain information based on the number of platelets in the blood sample. The operator can understand the influence of the number of platelets on the measurement results by referring to this information.
[0105] In addition, when the processing of steps S1 to S4 is performed, information related to the coagulation time can be obtained while information based on the platelet count can be obtained. That is, information based on the platelet count can be obtained while performing a coagulation test that is usually performed. In addition, since it is not necessary to perform measurements other than the measurements that are usually performed in order to obtain information based on the platelet count, a series of coagulation tests can be performed quickly, and the occurrence of situations such as the need for additional reagents in order to obtain information based on the platelet count can be avoided.
[0106] Next, the blood analysis method according to Embodiment 1 will be described in detail.
[0107] Figure 3 The process shown in the flowchart is to perform measurement for calculating the prothrombin time (PT) using the coagulation method in the coagulation analysis process, and to obtain information based on the platelet count using optical information obtained in the measurement. Figure 3 The processing details Figure 1 The processing shown and by Figure 2 , 4 The blood analysis device 10 shown performs.
[0108] In Embodiment 1, the optical information obtained in the determination for calculating the prothrombin time is used to obtain information based on the platelet count. The optical information used to obtain information based on the platelet count is not necessarily limited to the optical information obtained in the determination for calculating the prothrombin time. For example, it is also possible to design: a determination for calculating fibrinogen activity is performed, and the optical information obtained in the determination is used to obtain information based on the platelet count.
[0109] Figure 4 It's from above Figure 2 The structure of the measuring device 20 is shown in FIG. Figure 2 The structure shown also includes Figure 4 The structure shown.
[0110] like Figure 4 As shown, the measuring device 20 includes a transport unit 210 , a sample dispensing unit 220 , a reaction container stage 230 , a heating stage 240 , a reagent stage 250 , reagent dispensing units 260 and 270 , a transfer unit 280 , and a measuring unit 22 .
[0111] The transport unit 210 includes a rack placement part 211, a rack transport part 212, and a rack recovery part 213. The operator places the sample container 41 containing the blood sample on the sample rack 42, and sets the sample rack 42 on the rack placement part 211. The transport unit 210 transports the sample rack 42 set on the rack placement part 211 to the rack transport part 212, and sequentially places the sample containers 41 at the sample aspiration position 212a. After the sample aspiration of all the sample containers 41 placed on the sample rack 42 is completed, the transport unit 210 transports the sample rack 42 to the rack recovery part 213.
[0112] The sample dispensing unit 220 includes a nozzle 221, an arm 222, and a mechanism unit 223. The nozzle 221 is provided at the front end of the arm 222. The mechanism unit 223 rotates the arm in the circumferential direction and moves it in the vertical direction. Thus, the nozzle 221 can move in the circumferential direction and in the vertical direction. The sample dispensing unit 220 aspirates a blood sample from the sample container 41 located at the sample aspiration position 212a, and discharges the aspirated sample into the reaction container 43 placed in the placement hole 231 of the reaction container stage 230.
[0113] The reaction container table 230 has a ring shape in a plan view, and is disposed outside the reagent table 250. The reaction container table 230 can rotate in a circumferential direction. The reaction container table 230 has a plurality of placement holes 231 for placing the reaction containers 43.
[0114] The heating stage 240 has a plurality of receiving holes 241 for receiving the reaction container 43 and a transfer unit 242 for transferring the reaction container 43. The heating stage 240 has a circular outline in a plan view and can rotate in a circumferential direction. The heating stage 240 heats the reaction container 43 placed in the receiving holes 241 to 37°C.
[0115] After the blood sample is discharged into the reaction container 43 placed on the reaction container stage 230, the reaction container stage 230 rotates, and the reaction container 43 containing the blood sample is transferred to the vicinity of the heating stage 240. Then, the transfer unit 242 of the heating stage 240 clamps the reaction container 43 and places it in the placement hole 241 of the heating stage 240.
[0116] The reagent table 250 can hold a plurality of reagent containers 251 containing reagents used in coagulation test related measurements. The reagent table 250 rotates in a circumferential direction. The reagent table 250 holds a plurality of reagent containers 251 containing reagents used in the measurement of measurement items, such as a reagent container 251 containing a reagent for measuring prothrombin time, a reagent container 251 containing a reagent for measuring fibrinogen, etc.
[0117] The reagent dispensing section 260 includes a nozzle 261 and a mechanism section 262. The mechanism section 262 moves the nozzle 261 in the horizontal direction so that it crosses the reagent table 250, and moves the nozzle 261 in the vertical direction. Similarly, the reagent dispensing section 270 includes a nozzle 271 and a mechanism section 272. The mechanism section 272 moves the nozzle 271 in the horizontal direction so that it crosses the reagent table 250, and moves the nozzle 271 in the vertical direction. The reagent dispensing sections 260 and 270 are arranged on the lower side of the upper side of the housing of the measuring device 20.
[0118] The reagent dispensing parts 260 and 270 dispense reagents into the reaction container 43 heated on the heating stage 240. When dispensing the reagents, the transfer part 242 or the transfer part 280 takes out the reaction container 43 from the placement hole 241 of the heating stage 240 and places it at a certain position near the heating stage 240. Then, the reagent dispensing parts 260 and 270 aspirate the reagent from the reagent container 251 via the nozzles 261 and 271, and discharge the aspirated reagent into the reaction container 43. Thus, the reagent is mixed with the blood sample to prepare the blood test specimen. Figure 2 The preparation section 21 corresponds to the heating stage 240 , the reagent stage 250 , the reagent dispensing sections 260 and 270 , and the transfer section 280 . Then, the transfer section 280 sets the reaction container 43 in the placement hole 22 d of the measurement section 22 .
[0119] The measuring section 22 includes a plurality of receiving holes 22d. The measuring section 22 irradiates the reaction container 43 received in the receiving hole 22d with light by the irradiating section 22a, and receives the light transmitted through the blood sample by the detecting section 22b.
[0120] return Figure 3 In step S11, the measuring device 20 performs the first measurement based on the blood sample. In the first embodiment, the first measurement is a measurement related to the measurement item "PT", which is a measurement for calculating the prothrombin time. In addition, it can also be designed that the first measurement is a measurement related to the measurement item "Fbg", which is a measurement for calculating the fibrinogen activity. The blood sample supplied to the first measurement is plasma obtained by centrifuging a whole blood sample collected from the subject. The whole blood sample collected from the subject is contained in a sample container 41 containing sodium citrate. By centrifuging the sample container 41, plasma from which blood cell components are removed from the whole blood sample to which sodium citrate is added is obtained.
[0121] In addition, the blood sample supplied to the first measurement is not limited to plasma, and may be, for example, whole blood. In this case, the first measurement may be a measurement for measuring the coagulation time.
[0122] Specifically, the following processing is performed in step S11. The sample dispensing section 220 aspirates the blood sample from the sample container 41 transported by the transport unit 210 and discharges it into the reaction container 43 of the reaction container stage 230. The reaction container 43 is transferred by the reaction container stage 230 and the transfer section 242, and is placed in the placement hole 241 of the heating stage 240. The heating stage 240 heats the blood sample in the reaction container 43. The transfer section 280 takes out the reaction container 43 from the placement hole 241 and places it in a position for dispensing reagents. The reagent dispensing section 270 dispenses the prothrombin time measurement reagent into the reaction container 43 placed by the transfer section 280. In this way, a mixed solution of the blood sample and the prothrombin time measurement reagent is prepared, that is, a blood sample for the first measurement is prepared.
[0123] The reagent for measuring the prothrombin time is, for example, a reagent containing thromboplastin, specifically Thromborel S and Thrombocheck PT manufactured by Sysmex Corporation. In addition, when the first measurement is a measurement related to the measurement item "Fbg", the preparation unit 21 mixes the blood sample and the reagent for measuring fibrinogen to prepare a blood sample for the first measurement. The reagent for measuring fibrinogen is, for example, a reagent containing thrombin, specifically Thrombocheck Fib (L) manufactured by Sysmex Corporation. The reagent dispensing unit 270 aspirates the reagent used in the first measurement from the reagent container 251 and discharges it to the reaction container 43 containing the blood sample to prepare the blood sample.
[0124] After the reagent dispensing section 270 performs reagent dispensing, the transfer section 280 places the reaction container 43 in the placement hole 22d. The measuring section 22 irradiates the blood sample for the first measurement with 660nm light through the irradiation section 22a, and receives the transmitted light of the blood sample through the detection section 22b. The measuring section 22 processes the detection signal output from the detection section 22b through the signal processing section 22c, and obtains the measurement data. In addition, when the first measurement is a measurement related to the measurement item "Fbg", the measuring section 22 irradiates the blood sample with 405nm light through the irradiation section 22a. In step S12, the measuring device 20 sends the measurement data obtained in step S11 to the control device 30.
[0125] After the first measurement is performed using the reagent for measuring the prothrombin time and the reagent for measuring the fibrinogen, information based on the number of platelets in the blood sample can be obtained based on the optical information in a certain time range as described later. In addition, since the optical information is obtained in the first measurement in which the measurement items are "Fbg", "Fib", etc., i.e., in the measurement process of measuring the coagulation time of the blood sample, information based on the number of platelets can be obtained based on this process, and the coagulation time can also be calculated in this process.
[0126] In steps S21 to S23 , the processing unit 31 of the control device 30 performs a process of calculating the time required until the coagulation reaction ends based on the measurement data received from the measurement device 20 , that is, a process of calculating the prothrombin time based on the first measurement.
[0127] Here, refer to Figure 5 and Figure 6 (a) Explanation of steps S21 to S23.
[0128] Figure 5 This represents the basic shape of the coagulation curve used to calculate the time required for the coagulation reaction to end. Figure 5 As shown, the shape of a general solidification curve is, for example, an s-curve shape. The solidification curve includes a curve of a first shape, in which the value of the vertical axis decreases as the value of the horizontal axis increases, and a curve of a second shape, in which the value of the vertical axis increases as the value of the horizontal axis increases. Figure 5 The shape shown is the first shape.
[0129] In addition, when the measured data is based on the amount of transmitted light, the general coagulation curve is Figure 5 The first shape shown, when the measurement data is based on the scattered light amount, the general coagulation curve is the second shape. In addition, when the absorbance is calculated from the measurement data based on the transmitted light amount, the general absorbance curve is the second shape, and when the absorbance is calculated from the measurement data based on the scattered light amount, the general absorbance curve is the first shape.
[0130] like Figure 5 As shown, if it is a normal coagulation curve without abnormalities, the amount of transmitted light before the coagulation reaction starts is basically constant. The amount of transmitted light decreases at the start of the coagulation reaction. In addition, if it is a normal coagulation curve without abnormalities, the amount of transmitted light after the coagulation reaction stops is basically constant.
[0131] The solidification curve is Figure 5 The solidification time is calculated based on the shape shown in the figure. As an example of calculating the solidification time, Figure 5 The percentage detection method is shown. The percentage detection method is a method in which the transmitted light amount of the baseline at the start point of the coagulation reaction is 0%, the transmitted light amount of the coagulation reaction stop point, i.e., the coagulation end point, is 100%, and the time when the transmitted light amount reaches the coagulation detection % is calculated as the coagulation time. The coagulation detection % is set to a value that is a certain ratio relative to the interval between the transmitted light amount of the baseline and the transmitted light amount of the coagulation reaction stop point. The coagulation detection % is used to find the coagulation point where the transmitted light amount changes from the baseline by the coagulation detection %. The coagulation detection % is set to a value greater than 0% and less than 100%. For example, the coagulation detection % is set to 50%.
[0132] The processing unit 31 executes the program 32a. Figure 3 The processing of steps S21 to S24 is shown.
[0133] Figure 3 In step S21, the processing unit 31 searches for the coagulation curve data based on the received measurement data. Figure 5 The point with the largest amount of transmitted light in the baseline search interval is the starting point of the coagulation reaction. The baseline search interval is set to a certain period from the start of detection. The baseline search interval is, for example, the period from the start of detection to 60 seconds, excluding a certain masking time set immediately after the start of detection. In the coagulation curve data, data corresponding to the baseline search interval is used for baseline search. In addition, the masking time is, for example, several seconds. The processing unit 31 determines the amount of transmitted light at the starting point of the coagulation reaction found as the baseline.
[0134] Figure 3 In step S22, the processing unit 31 searches for the coagulation end point of the coagulation curve data as the point where the coagulation reaction stops. The coagulation end point is the end point of the time range used to calculate the coagulation time of the blood sample based on the first measurement. The coagulation end point is searched in the period after the time point when the difference between the baseline and the amount of transmitted light exceeds a certain coagulation reaction start level, that is, the coagulation reaction stop search interval. In the coagulation curve data, the data of the coagulation reaction stop search interval is used to search for the coagulation end point. As will be referred to Figure 6 As explained in (a), when searching for the coagulation end point, we search for the point where the change in the amount of transmitted light becomes smaller.
[0135] like Figure 6 As shown in (a), in the search for the coagulation end point, the processing unit 31 sets a determination point and a comparison point after a time ΔT1 has passed from the determination point on the coagulation curve. Then, when the difference ΔL1 in the amount of transmitted light between the determination point and the comparison point is less than a certain threshold, the processing unit 31 sets the determination point as the coagulation end point.
[0136] In addition, the search for the end point of solidification is not limited to Figure 6 The steps shown in (a) can also be Figure 6 (b) The steps shown, Figure 6 (c) The steps shown.
[0137] in the case of Figure 6 In the case of the modification example shown in (b), the processing unit 31 sets a determination point and a comparison point after a time ΔT2 has passed from the determination point on the coagulation curve. The time ΔT2 is equal to the time interval between the coagulation reaction start point and the determination point. If the slope of the straight line connecting the coagulation reaction start point and the determination point is SL1, and the slope of the straight line connecting the determination point and the comparison point is SL2, when the value of SL2 / SL1 is smaller than a certain threshold value, the processing unit 31 sets the determination point as the coagulation end point.
[0138] in the case of Figure 6 In the case of the modification shown in (c), the processing unit 31 sets a determination point, a first comparison point at a time ΔT3 before the determination point, and a second comparison point at a time ΔT3 after the determination point on the coagulation curve. The processing unit 31 draws straight lines upward from the determination point, the first comparison point, and the second comparison point to the baseline, and sets the area surrounded by the oblique line between the baseline and the coagulation curve. If the processing unit 31 sets the area of the oblique line area on the first comparison point side to s1 and the area of the oblique line area on the second comparison point side to s2, when the value of s2 / s1 is smaller than a certain threshold value, the processing unit 31 sets the determination point as the coagulation end point.
[0139] Figure 3 In step S23, the processing unit 31 obtains the time when the transmitted light amount reaches the coagulation detection % as the coagulation time, namely, the prothrombin time, based on the percentage detection method. The prothrombin time is the measurement result obtained based on the first measurement, namely, the measurement result of the measurement item "PT".
[0140] Next, Figure 3 In step S24, the processing unit 31 performs a process for acquiring information based on the platelet count. Specifically, through the process of step S24, the processing unit 31 acquires information related to the platelet count, the necessity of additional processing of the blood sample, and the influence on the second measurement different from the first measurement as information based on the platelet count.
[0141] In addition, as long as the coagulation end point is obtained before starting step S24, information based on the platelet count can be obtained in step S24. Figure 3 In the processing shown, if only information based on the number of platelets needs to be obtained, the processing for obtaining the coagulation time in step S23 may be omitted.
[0142] Here, refer to Figure 5 The outline of the processing contents of step S24 will be described.
[0143] The processing unit 31 sets the interval corresponding to the end stage of the coagulation reaction of the blood sample as the index value acquisition interval. The end stage of the coagulation reaction includes not only the coagulation end point, but also the interval immediately before the coagulation end point, any time point after the coagulation end point, and all other time periods in which the same amount of transmitted light as that detected at the coagulation end point can be detected.
[0144] In the first embodiment, the processing unit 31 sets a certain time range including the time point after the coagulation end point as the index value acquisition interval. In addition, in the first embodiment, the starting point of the index value acquisition interval is set as the coagulation end point, and the time from the start to the end of the index value acquisition interval, that is, the time period of the index value acquisition interval is set to 5 seconds, for example. The processing unit 31 connects the point on the coagulation curve at the starting point of the index value acquisition interval and the point on the coagulation curve at the end point of the index value acquisition interval with a straight line, and calculates the slope of the straight line.
[0145] The inventors have conducted various tests and found that the change in optical information at the end of the coagulation reaction varies depending on the number of platelets in the blood sample. Specifically, the inventors found that when the blood sample contains many platelets, the amount of transmitted light in the index value acquisition interval corresponding to the end of the coagulation reaction increases slightly. Based on this insight, the inventors found that the number of platelets in the blood sample can be inferred based on the slope of the straight line obtained from the index value acquisition interval.
[0146] In addition, when the measurement data is based on the amount of scattered light, a general coagulation curve is a second shape obtained by inverting the first shape in the up-down direction. Therefore, by determining the up-down direction, the coagulation time can be obtained in steps S21 to S23 through the same steps as above, and the information based on the platelet count can be obtained in step S24. In addition, when the coagulation time is obtained based on the absorbance, the coagulation time can be obtained in steps S21 to S23 through the same steps, and the information based on the platelet count can be obtained in step S24.
[0147] Next, refer to Figure 7 illustrate Figure 3 The step S24 is based on the acquisition process of the information on the number of platelets.
[0148] In step S101, the processing unit 31 obtains an index value indicating a change in optical information based on the optical information in the index value acquisition interval. Figure 8 As shown in (a), in Embodiment 1, the starting point of the index value acquisition interval is set to the coagulation end point, and the time period of the index value acquisition interval is set to 5 seconds.
[0149] In addition, the index value acquisition interval can be set to the interval near the solidification end point. Figure 8 As shown in (b), it can also be designed as follows: the starting point of the index value acquisition interval is set before the solidification end point, and the end point of the index value acquisition interval is set after the solidification end point. Figure 8 As shown in (c), it can also be designed as follows: the starting point and the end point of the index value acquisition interval are set to the end point of solidification. Figure 8As shown in (d), it can also be designed that the starting point and the end point of the index value acquisition interval are set before the coagulation end point. In addition, the time period of the index value acquisition interval is not limited to 5 seconds, and can be more than 1 second and less than 90 seconds. As shown in the verification described later, the time period of the index value acquisition interval is preferably more than 5 seconds and less than 10 seconds.
[0150] Specifically, the processing unit 31 calculates the slope of a straight line connecting a point on the coagulation curve at the start point of the index value acquisition interval and a point on the coagulation curve at the end point of the index value acquisition interval as the index value.
[0151] In addition, as described above, when the optical information is the amount of transmitted light, the processing unit 31 may calculate the amount of change in the amount of transmitted light from the start point to the end point of the index value acquisition interval as the index value. In addition, when the optical information is the amount of scattered light, the processing unit 31 calculates the change speed or amount of change in the amount of scattered light based on the amount of scattered light at the start point and the end point of the index value acquisition interval as the index value. In addition, when the optical information is absorbance, the amount of transmitted light at the start point of the index value acquisition interval is I1, the amount of transmitted light at the end point of the index value acquisition interval is I2, and the time period of the index value acquisition interval is ΔT, the processing unit 31 calculates the change speed based on the following formula (1) or the change amount based on the following formula (2) as the index value.
[0152] Change rate = {log 10 (I1 / I2)} / ΔT … (1)
[0153] Change = log 10 (I1 / I2) …(2)
[0154] By acquiring the change speed or the change amount as the index value in this way, it is possible to easily grasp the change state of the optical information in the index value acquisition section.
[0155] In addition, the index value is not limited to the point on the coagulation curve at the beginning of the index value acquisition interval and the point on the coagulation curve at the end of the index value acquisition interval. For example, when the index value is the change rate, the index value can be the value obtained by averaging the slope of the coagulation curve every 0.1 seconds; when the index value is the change amount, the index value can be the value obtained by averaging the change amount from the starting point every 0.1 seconds. In addition, the index value is not limited to the average of each value, and can also be based on the variance of each value, or the average of the square of each value.
[0156] In step S102, the processing unit 31 obtains the number of platelets in the blood sample based on the slope obtained as the index value in step S101 and the table pre-stored in the storage unit 32. According to the verification of the inventors, it is found that the larger the value of the slope is, the greater the number of platelets in the blood sample is. As shown in the verification described later, the correlation between the slope and the number of platelets is basically as follows: Fig. 9 (a) is shown in the diagram. Therefore, as long as we use Fig. 9 (a) The points on the curve are Fig. 9 If the table shown in (b) is used as a table showing the correlation between the slope and the platelet count, the platelet count can be obtained from the slope. Fig. 9 (b) Take at a certain interval Fig. 9 The points on the curve of (a) are expressed in the form of a table.
[0157] In step S102, the processing unit 31 refers to the slope obtained in step S101. Fig. 9 (b) The platelet count is obtained from the table shown in FIG. The platelet count in the table is, for example, the number of platelets contained per 1 μL. In addition, when the slope obtained in step S101 is Fig. 9 When the platelet count is between the first slope and the second slope in the table (b), the processing unit 31 calculates a value between the platelet count corresponding to the first slope and the platelet count corresponding to the second slope as the platelet count. By obtaining the platelet count as information based on the platelet count, the operator can understand the extent to which the blood sample contains platelets and can directly determine the influence of the platelet count on the measurement result.
[0158] In addition, it is possible to store Fig. 9 (a) instead of storing a table in the storage unit 32. At this time, the processing unit 31 calculates the slope obtained in step S101 and the expression Fig. 9 The platelet count was calculated using the formula in the graph shown in (a).
[0159] In step S103, the processing unit 31 compares the platelet count obtained in step S102 with several threshold values. The threshold value compared in step S103 corresponds to the second reference value. Several threshold values are, for example, 10,000 / μL, 30,000 / μL, and 50,000 / μL. These threshold values are used to determine the number of platelets contained in the blood sample. In particular, 10,000 / μL is the boundary value of the platelet count that needs to be guaranteed in order to control the impact on the measurement results, as recorded in the Journal of the Japanese Society of Hematology, Vol. 17, No. 2, "Consensus on Coagulation Test Sample Processing". That is, as long as the platelet count is less than 10,000 / μL, the impact of platelets on the measurement results is very small. In addition, the threshold value compared with the platelet count can be 1, for example, only the threshold of 10,000 / μL can be used.
[0160] In step S104, the processing unit 31 obtains information related to the influence on the second measurement and information related to the necessity of additional processing of the blood sample as information based on the platelet count based on the comparison result of step S103. In other words, the information obtained here is information based on the level of the platelet count in the blood sample, and the information related to the influence on the second measurement is information for indicating the existence of measurement items affected by the platelets in the blood sample. If the information based on the level of the platelet count in the blood sample is obtained, the operator can determine whether the platelet count in the blood sample exceeds each threshold value by referring to the information.
[0161] Here, the second measurement refers to a measurement related to the measurement item "PT", that is, a measurement different from the first measurement. The platelets contained in the blood sample are not likely to affect the measurement result of the first measurement, but sometimes they may have a negative impact on the measurement result of the second measurement. The measurement items of the first measurement may include "PT" and "Fbg". The measurement items of the second measurement may include, for example, "lupus anticoagulant (LA)", "coagulation factor XIII", "pai-1", etc. In this way, when the number of platelets in the blood sample is large, sometimes the measurement result of the second measurement may be inappropriate even if the measurement result of the first measurement is appropriate. At this time, if the relevant information on the impact on the second measurement is obtained as information based on the platelet count, the operator can determine whether the measurement result of the second measurement is appropriate.
[0162] Additional blood sample processing refers to additional processing for obtaining an appropriate blood sample. For example, additional blood sample processing is processing for re-centrifuging an already obtained blood sample of a subject and re-obtaining a blood sample, or re-collecting a whole blood sample from a subject and then centrifuging the whole blood sample and re-obtaining a blood sample. If information related to the necessity of additional processing is obtained as information based on the platelet count, the operator can determine whether it is necessary to obtain a blood sample in an appropriate state again.
[0163] In step S105, the processing unit 31 displays the information based on the platelet count on the display unit 33 according to the display instruction input by the operator via the input unit 34. The operator can thereby visually grasp the information based on the platelet count in the blood sample. In this way, the acquisition process of the information based on the platelet count is completed.
[0164] Next, refer to Figures 10-12 illustrate Figure 7 The interfaces 110 , 120 , and 130 are displayed on the display unit 33 in step S105 .
[0165] like Fig.10 As shown, the interface 110 includes a list 111 and a display details button 112 .
[0166] The information of each blood sample is displayed in the list 111. The display items of the list 111 include the status, sample number, end time, start time, date, and the measurement result of each measurement item.
[0167] in addition, Figure 3 and Figure 7 In the process shown, the blood analyzer 10 performs only the first measurement, obtains the measurement result of the coagulation time, i.e., the measurement item "PT", based on the first measurement, and obtains information based on the platelet count. However, when a measurement instruction including other measurement items other than the measurement item "PT" is set for a blood sample, the blood analyzer 10 performs other measurements other than the first measurement according to the measurement instruction, and obtains the measurement results based on the other measurements. The measurement items of the other measurements can include activated partial thromboplastin time (APTT), lupus anticoagulant (LA), coagulation factor XIII, pai-1, etc.
[0168] like Fig.10 As shown, one horizontally extended row in the list 111 corresponds to one blood sample. Fig.10 In the example shown, measurement results of measurement items "PT", "Fib", and "LA" are displayed for each blood sample. In addition, the list 111 is provided with a scroll bar extending in the vertical direction for displaying all blood samples and a scroll bar extending in the horizontal direction for displaying all measurement results.
[0169] For example, "Review" is displayed in the display item "status." "Review" indicates that the platelet count of the corresponding blood sample may be high. Fig.10 In the example, for sample numbers "0002" and "0004", Figure 7 In step S103, the result of comparing the platelet count with the threshold value is that the blood sample contains more than 10,000 platelets / μL, so "Review" is displayed in the status display item. In this way, for the blood sample that is determined to contain more than 10,000 platelets / μL and displays "Review", Figure 7 In step S104, it is determined that the second measurement is affected, and it is determined that additional processing is necessary to obtain an appropriate blood sample. That is, the displayed "Review" is information related to the impact on the second measurement and is information related to the necessity of additional processing.
[0170] In this way, when "Review" is displayed, numerical values are displayed as measurement results in measurement items other than those related to the second measurement, such as the measurement items "PT" and "Fib" of the first measurement, but "*" and "---" indicating that the measurement results are masked are displayed in the measurement items related to the second measurement. Such masked display is also information related to the impact on the second measurement and the necessity of additional processing. Alternatively, it can be designed so that "*" that needs to mask the measurement results is displayed in the measurement items related to the second measurement, and numerical values are displayed at the measurement results.
[0171] When the operator wishes to confirm detailed information about the blood sample, the operator selects a row of the corresponding blood sample in the list 111 via the input unit 34. As a result, a frame 111a appears in the row of the corresponding blood sample. Then, the operator operates the display details button 112 via the input unit 34. As a result, the processing unit 31 displays the interface 120 including detailed information about the selected blood sample on the display unit 33.
[0172] like Fig.11 As shown, the interface 120 includes a sample number display area 121 , lists 122 , 123 , a graph display area 124 , and a display button 125 .
[0173] The sample number display area 121 displays the sample number of the blood sample displayed on the interface 120. The list 122 displays the measurement results of all measurement items performed on the blood sample displayed on the interface 120. The list 122 is provided with a scroll bar extending in the up and down directions that can display all the measurement results. When the operator wants to display detailed information related to the measurement results, he selects the row of the corresponding measurement item in the list 122. As a result, a frame 122a appears in the row of the corresponding measurement item. After selecting the row of the measurement item in the list 122, the list 123 and the chart display area 124 will display detailed information related to the corresponding measurement item.
[0174] The list 123 displays detailed numerical information related to the measurement item selected in the list 122 . Fig.11 In the example, since "PT" is selected as the measurement item, the display items of the list 123 include the coagulation reaction start time, the transmitted light amount of the baseline, the coagulation reaction stop time, the reaction intensity, the coagulation detection %, the absorbance, the time period of the index value acquisition interval, and the slope.
[0175] The coagulation reaction start time is the time when the coagulation reaction starts. The coagulation reaction stop time is the time when the coagulation stops. The reaction intensity is obtained by subtracting the transmitted light at the coagulation stop point from the transmitted light at the baseline. The absorbance is a value corresponding to the turbidity of the blood sample, and is calculated based on the transmitted light at the baseline and the transmitted light at the coagulation stop point. The time period of the index value acquisition interval is Figure 7 The slope is the value used when obtaining the index value in step S101. Figure 7 The index value obtained in step S101 can also be designed as follows: an input interface is provided to enable the operator to set the time period of the index value acquisition interval.
[0176] The graph display area 124 displays a graph obtained by measurement related to the measurement item selected in the list 122 . Fig.11 In the example of , since “PT” is selected as the measurement item, the graph display area 124 displays the coagulation curve obtained by the first measurement related to the measurement item “PT”.
[0177] The display button 125 is a button for displaying information based on the platelet count. When the operator wants to display information based on the platelet count for the blood sample displayed on the interface 120, the operator operates the display button 125 via the input unit 34. As a result, the processing unit 31 displays the interface 130 including the information based on the platelet count on the display unit 33.
[0178] like Fig.12 As shown, the interface 130 includes a sample number display area 131 , a list 132 , a graph display area 133 , and a comment area 134 .
[0179] The sample number display area 131 displays the sample number of the blood sample displayed on the interface 130. The list 132 displays the slope and platelet count obtained based on the blood sample displayed on the interface 120. The chart display area 133 displays a chart showing the results of comparing the slope and platelet count displayed in the list 132 with the threshold values. The chart display area 133 shows that there are 3 threshold values for comparison with the slope and 3 threshold values for comparison with the platelet count. The threshold value indicated by the bottom dotted line among these threshold values is the threshold value corresponding to the platelet count of 10,000 / μL. The display content of the chart display area 133 is also information based on the level of the platelet count in the blood sample. It can also be designed as follows: an input interface is provided to allow the operator to set 3 threshold values related to the slope and the platelet count.
[0180] The comment area 134 displays information related to the influence on the second measurement and information related to the necessity of additional processing. Fig.12 In the example, because the platelet count is more than 10,000 / μL, the comment area 134 displays "The platelet count may be high". In addition, because the platelet count may be high, the comment area 134 displays that the second measurement may be affected, and specifically displays the measurement items of the second measurement that may be affected. The comment area 134 may also display "The measurement result of the second measurement may be inappropriate". In addition, "It is necessary to re-centrifuge or re-acquire the blood sample" is displayed as relevant information on the necessity of additional processing.
[0181] Next, the flow of an inspection performed by an operator using the above-described blood analysis process will be described.
[0182] like Fig.13 As shown, in step S201, the operator obtains a whole blood sample from the subject. In step S202, the operator obtains a blood sample from the whole blood sample. Specifically, the operator uses a centrifuge to centrifuge the whole blood sample and obtains plasma as the blood sample. In step S203, the operator uses the input unit 34 of the blood analysis device 10 to input the input unit 34 for executing the blood analysis. Figure 3 , 7 The blood analysis process is performed based on the blood sample. Figure 3 , 7 processing.
[0183] In step S204, the operator confirms Figure 7 The operator checks the display contents of the screens 110, 120, and 130 displayed in step S105, and confirms the platelet count, the necessity of additional processing of the blood sample, and the influence on the second measurement. Based on the contents confirmed in step S204, the operator determines whether it is necessary to perform additional processing of the blood sample, that is, to centrifuge the blood sample again or to obtain the whole blood sample again.
[0184] When the operator determines that it is necessary to centrifuge the blood sample again, the determination result of step S205 is yes, and the processing returns to step S202. In step S202, the operator re-centrifuges the blood sample already obtained in step S201 and obtains the blood sample again. Then the operator performs the processing of step S203 and thereafter. In addition, when the operator determines that it is necessary to obtain a whole blood sample again, the determination result of step S206 is yes, and the processing returns to step S201. The operator obtains a whole blood sample from the subject again in step S201. Then, the operator obtains the blood sample again in step S202 and performs the processing of step S203 and thereafter. When the operator determines that it is not necessary to perform re-centrifugation and re-acquisition, Fig.13 The processing is finished.
[0185] Like this, the operator confirms that Figure 7 When it is determined that additional blood sample processing is necessary based on the displayed content of step S105, the blood sample is centrifuged again, the whole blood sample is obtained again, and the blood sample is obtained again. This allows smooth and appropriate inspection.
[0186] <Verification>
[0187] Next, verification performed by the inventors will be described.
[0188] The inventors used a coagulation analyzer "CS-5100" manufactured by Sysmex Corporation to measure and analyze the measurement item "PT" based on a blood sample containing a certain number of platelets prepared in advance.
[0189] In the preparation of blood samples, the inventor collected whole blood samples from healthy people A to C, and prepared 7 blood samples with different platelet counts from each whole blood sample. At this time, the inventor obtained blood samples with almost zero platelet counts after sufficient centrifugation and blood samples with a certain amount of platelet counts after insufficient centrifugation from the whole blood samples. Then, the inventor measured the blood samples with a certain amount of platelet counts using CS-5100 and obtained the platelet count, i.e., the concentration of platelets.
[0190] The inventor mixed a blood sample that was fully centrifuged to have a platelet count of almost 0 with a blood sample that had a platelet concentration, thereby preparing 7 blood samples containing a certain number of platelets from 1 whole blood sample. The 7 blood samples prepared here are blood samples containing 0 / μL, 1,000 / μL, 3,000 / μL, 10,000 / μL, 30,000 / μL, 100,000 / μL, and 300,000 / μL of platelets. In this way, the inventor obtained 7 blood samples with different concentrations from 1 whole blood sample.
[0191] Next, the inventor used a coagulation analysis device to measure the measurement item "PT" on a total of 21 blood samples and obtained Fig.14 (a) ~ Fig.16 (g) shows the coagulation curve. For the PT measurement, Thromborel S manufactured by Sysmex Corporation was used as a reagent for measuring the coagulation time. Fig.14 (a) to (g) show the coagulation curves of 7 blood samples prepared from healthy person A. Similarly, Fig.15 (a) to (g) show the coagulation curves of seven blood samples prepared from healthy person B. Fig.16 (a) to (g) show the coagulation curves of seven blood samples prepared from healthy person C. Fig.14 (a) ~ Fig.16 In the graph of (g), the horizontal axis represents the elapsed time, and the vertical axis represents the amount of transmitted light. The black circle mark on the coagulation curve represents the coagulation end point.
[0192] from Fig.14 (a) ~ Fig.16 The results of (g) show that the slope near the coagulation end point increases as the number of platelets in the blood sample increases for healthy subjects A to C. Therefore, it can be said that the optical information during the acquisition of the index value near the coagulation end point can be used to obtain information based on the number of platelets in the blood sample.
[0193] In addition, when the blood sample contains a certain number of platelets, the phenomenon that the amount of transmitted light increases again after the coagulation termination point, that is, the phenomenon that the absorbance decreases after the coagulation termination point, is because the platelets in the blood sample activate fibrin evolved from fibrinogen.
[0194] Fig.17 (a) is a graph showing the values of the slopes obtained based on the above 21 blood samples in the same steps as in Implementation Example 1 when the starting point of the index value acquisition interval is the coagulation termination point and the time period of the index value acquisition interval is changed. The 7 broken lines on the graph represent the slopes when the time period of the index value acquisition interval is 1 second, 3 seconds, 5 seconds, 10 seconds, 30 seconds, 60 seconds, and 90 seconds. The horizontal axis of the graph represents blood samples containing 0 platelets / μL, 1,000 / μL, 3,000 / μL, 10,000 / μL, 30,000 / μL, 100,000 / μL, and 300,000 / μL. The vertical axis of the graph represents the values of the slopes obtained. Three blood samples containing a certain number of platelets were prepared based on healthy people A~C, and the black circle marks on the graph are the average values obtained from the slopes of the three blood samples containing the same number of platelets.
[0195] like Fig.17 As shown in (a), it can be seen that no matter how the time period of the index value acquisition interval is set, the slope will basically increase if the number of platelets contained in the blood sample increases. Therefore, it can be said that the number of platelets contained in the blood sample can be inferred based on the slope obtained when the starting point of the index value acquisition interval is the coagulation termination point. In addition, when the time period of the index value acquisition interval is 5 seconds and 10 seconds, the slope also increases almost monotonically with the increase in the number of platelets, and the difference in slope when the number of platelets is 1,000 / μL and when the number of platelets is 300,000 / μL is large. Therefore, it can be said that setting the time period of the index value acquisition interval to more than 5 seconds and less than 10 seconds will improve the resolution in the vertical axis direction, so the number of platelets contained in the blood sample can be inferred with high accuracy.
[0196] In addition, in Embodiment 1, the following Fig. 9 (b) shows the correlation between slope and platelet count, and the source of this table is Fig. 9 For example, the diagram shown in (a) is Fig.17 The chart in (a) is based on the time period of the indicator value acquisition interval of 5 seconds.
[0197] Fig.17(b) is a graph showing the values of the slope obtained based on the above 21 blood samples in the same steps as in Implementation Example 1 when the starting point of the index value acquisition interval is set to 3 seconds before the coagulation end point and the time period of the index value acquisition interval is changed. At this point, it can be seen that regardless of how the time period of the index value acquisition interval is set, the slope will basically increase as the number of platelets contained in the blood sample increases. Therefore, it can be said that the number of platelets contained in the blood sample can be inferred based on the slope obtained when the starting point of the index value acquisition interval is set to 3 seconds before the coagulation end point. In addition, it can be said that when the time period of the index value acquisition interval is set to more than 5 seconds and less than 10 seconds, based on Fig.17 (a) The number of platelets contained in a blood sample can be estimated with high accuracy for the same reason.
[0198] Fig.17 The graph of (c) shows the values of the slope obtained based on the above 21 blood samples in the same steps as in Implementation Example 1, when the starting point of the index value acquisition interval is set to 0.5 seconds after the coagulation end point and the time period of the index value acquisition interval is changed. It can also be seen at this time that no matter how the time period of the index value acquisition interval is set, the slope will basically increase as the number of platelets contained in the blood sample increases. Therefore, it can be said that the number of platelets contained in the blood sample can be inferred based on the slope obtained when the starting point of the index value acquisition interval is set to 0.5 seconds after the coagulation end point. In addition, it can be said that the time period of the index value acquisition interval is set to be greater than 5 seconds and less than 10 seconds, and according to Fig.17 (a) For the same reason, the number of platelets contained in a blood sample can be estimated with high accuracy.
[0199] In addition, the inventors used a coagulation analysis device to measure the measurement item "Fbg" on a total of 7 blood samples and obtained Fig.18 Coagulation curves shown in (a) to (g). Thrombocheck Fib (L) manufactured by Sysmex Corporation was used as a reagent for measuring the coagulation time in the Fbg measurement. The blood samples at this time were the same as those used in the verification of the measurement item "PT" described above, and were set to 7 different concentrations.
[0200] from Fig.18 From the results of (a) to (g), it can be seen that in the case of the measurement item "Fbg", as the number of platelets contained in the blood sample increases, the slope after the coagulation termination point gradually increases. Therefore, it can be said that the optical information obtained based on the measurement of the measurement item "Fbg" can obtain information based on the number of platelets in the same way as in the first embodiment.
[0201] <Implementation method 2>
[0202] In implementation mode 2, Fig.19 The process of acquiring information based on the platelet count is shown. Fig.19 In the processing, Figure 7 Compared with the processing of the embodiment 1 shown in the figure, step S102 is omitted and step S111 is added instead of step S103. In the embodiment 2, step S102 is omitted, so step S111 is not used. Fig. 9 (b) is a table showing the correlation between the slope and the platelet count. The other processes and structures of the second embodiment are the same as those of the first embodiment.
[0203] In step S111, the processing unit 31 compares the index value obtained in step S101, that is, the slope, with several threshold values. For example, the several threshold values are the values of the slope corresponding to platelet counts of 10,000 / μL, 30,000 / μL, and 50,000 / μL. The threshold value compared in step S111 corresponds to the first reference value. Then, in step S104, the processing unit 31, like the first embodiment, obtains relevant information on the impact on the second determination and necessary relevant information for additional processing of the blood sample based on the comparison result of step S103 as information based on the platelet count. The information obtained at this time is the same as in the case of the first embodiment, which is information based on the level of the platelet count in the blood sample.
[0204] In step S105, the processing unit 31 displays information based on the platelet count on the display unit 33. In the second embodiment, the interfaces 110, 120, and 130 are displayed on the display unit 33 as in the first embodiment. However, the platelet count is not obtained in the second embodiment, so Fig.12 In the illustrated interface 130 , the display of the platelet count in the list 132 is omitted, and the display of the axis related to the platelet count in the graph display area 133 is omitted.
[0205] The index value, i.e., the slope, reflects the optical information of the index value acquisition interval, and changes according to the number of platelets in the blood sample. Therefore, instead of acquiring the number of platelets from the index value, relevant information on the influence on the second measurement and necessary relevant information for additional processing of the blood sample can be directly acquired from the index value. Thus, in the second embodiment, the operator can also determine whether the number of platelets in the blood sample exceeds the reference value by referring to the information based on the level of the number of platelets in the blood sample.
[0206] <Implementation method 3>
[0207] In implementation mode 3, Fig. 20 As shown, when a measurement instruction including measurement items of a first measurement and a second measurement is set for one blood sample, the second measurement is performed and notified to the operator based on information based on the platelet count. Fig. 20 In the processing, Figure 3Compared with the processing of the embodiment 1 shown in the figure, steps S13 and S14 are added to the latter stage of step S12, and steps S25 to S28 are added to the latter stage of step S24. In the embodiment 3, the first measurement is also the measurement of measurement items with little influence on the platelet count, such as PT and Fbg, and the second measurement is also the measurement of measurement items with great influence on the platelet count, such as activated partial thromboplastin time (APTT), lupus anticoagulant (LA), coagulation factor XIII, pai-1. The other processing and structure of the embodiment 3 are the same as those of the embodiment 1.
[0208] In step S25, the processing unit 31 determines whether the information based on the platelet count obtained in step S24 is above a certain threshold value. Specifically, the processing unit 31 determines whether the platelet count or the index value obtained in step S24 is above a certain threshold value. When the information based on the platelet count is above a certain threshold value, even if the second measurement is performed, an appropriate measurement result cannot be obtained, so the processing unit 31 does not send an instruction for the second measurement to the measurement device 20, and does not perform the second measurement. If the second measurement is not performed in this way, it is possible to prevent the second measurement from being performed on an inappropriate blood sample with a large number of platelets.
[0209] At this time, in step S26, the processing unit 31 performs the following processing: providing information indicating the influence on the second measurement; providing relevant information on the necessity of additional processing of the blood sample before the second measurement. Figure 7 In step S104, information indicating the influence on the second measurement and information related to the necessity of additional processing are provided, and when the information based on the platelet count is above a certain threshold, such information is provided in step S26. In this way, if the information indicating the influence on the second measurement is provided, the operator can understand the influence on the second measurement. In addition, if the information on the necessity of additional processing of the blood sample before the second measurement is provided, the operator can understand the necessity of additional processing.
[0210] In addition, if Fig.12 As shown, the above content is provided through the display of the display unit 33. However, it is not limited to this, and the above content can also be provided through sound. In addition, at least one of the following items can be performed: not performing the second measurement, providing information indicating the influence on the second measurement, and providing relevant information on the necessity of additional processing of the blood sample.
[0211] On the other hand, when the information based on the platelet count is less than a certain threshold value, in step S27, the processing unit 31 sends an instruction for the second measurement to the measuring device 20. After receiving the instruction for the second measurement, the measuring device 20 prepares a blood sample for the second measurement based on the blood sample and performs the second measurement in step S13. In step S14, the measuring device 20 sends the measurement data obtained in step S13 to the control device 30.
[0212] In step S28, the processing unit 31 analyzes the measurement items related to the second measurement based on the measurement data sent from the measurement device 20 in step S14, and displays the measurement results related to the second measurement on the display unit 33. In this way, the second measurement is performed only when the platelet count is judged to be small according to the first measurement, so that an appropriate measurement result of the second measurement can be obtained.
[0213]
Explanation of symbols
[0214] 10Blood analysis device
[0215] 22 Measurement Department
[0216] 22a Irradiation section
[0217] 22b Detection Department
[0218] 31 Processing Department
[0219] 32a Procedure
[0220] 33 Display unit
Claims
1. A blood analysis method comprising the following steps: After mixing a blood sample and a reagent for measuring a coagulation time, optical information changing with time is obtained from the mixed solution of the blood sample and the reagent. detecting the coagulation end point from the acquired optical information, acquiring an index value indicating a change in the optical information based on the optical information in a certain time range including a time point after the coagulation end point, Information based on the number of platelets in the blood sample is acquired based on the index value.
2. The blood analysis method according to claim 1, characterized in that: Information based on the number of platelets in the blood sample is acquired based on the optical information on the end stage of the coagulation reaction of the blood sample among the acquired optical information.
3. The blood analysis method according to claim 1 or 2, characterized in that: The information based on the number of platelets in the blood sample includes information related to the number of platelets or the necessity of additional processing of the blood sample.
4. The blood analysis method according to claim 1 or 2, characterized in that: The optical information is obtained based on a first measurement related to the coagulation time measurement, The information based on the platelet count in the blood sample includes information related to the influence on a second measurement different from the first measurement.
5. The blood analysis method according to claim 1, characterized in that: The index value is a change speed or a change amount of the optical information within the certain time range.
6. The blood analysis method according to claim 5, characterized in that: The change speed or change amount is acquired based on the optical information at the start point and the end point of the certain time range.
7. The blood analysis method according to claim 1, characterized in that: By comparing the index value with one or more preset first reference values, information on the level of the number of platelets in the blood sample is acquired as the information on the number of platelets in the blood sample.
8. The blood analysis method according to claim 1, characterized in that: The number of platelets in the blood sample is acquired based on the index value as information based on the number of platelets in the blood sample.
9. The blood analysis method according to claim 8, characterized in that: The number of platelets in the blood sample is acquired from the index value using information indicating a relationship between the index value and the number of platelets.
10. The blood analysis method according to claim 8, characterized in that: By comparing the number of platelets in the blood sample with one or more preset second reference values, information based on the level of the number of platelets in the blood sample is further acquired as information based on the number of platelets in the blood sample.
11. The blood analysis method according to claim 8, characterized in that: Based on the platelet count in the blood sample, information indicating the presence of a measurement item affected by the platelets in the blood sample or information related to the necessity of additional processing of the blood sample is acquired as information based on the platelet count in the blood sample.
12. The blood analysis method according to claim 1 or 2, characterized in that: Information based on the number of platelets in the blood sample is displayed on a display unit.
13. The blood analysis method according to claim 1, characterized in that: The optical information is acquired in the step of determining the coagulation time of the blood sample.
14. The blood analysis method according to claim 13, characterized in that: The coagulation end point is the end point of a time range for calculating the coagulation time of the blood sample.
15. The blood analysis method according to claim 1, characterized in that: The starting point of the certain time range is set to be after the coagulation end point.
16. The blood analysis method according to claim 1, characterized in that: The length of the certain time range is not less than 5 seconds and not more than 10 seconds.
17. The blood analysis method according to claim 1 or 2, characterized in that: The blood sample is plasma.
18. The blood analysis method according to claim 17, characterized in that: The whole blood sample is centrifuged to obtain the plasma.
19. The blood analysis method according to claim 1 or 2, characterized in that: The optical information is the intensity of transmitted light or the intensity of scattered light detected by irradiating the blood sample with light, or absorbance calculated from the intensity of the transmitted light or the intensity of the scattered light.
20. The blood analysis method according to claim 1 or 2, characterized in that: The reagent is a reagent for measuring prothrombin time or a reagent for measuring fibrinogen.
21. The blood analysis method according to claim 1 or 2, characterized in that: When it is determined based on information based on the number of platelets in the blood sample that additional processing of the blood sample is necessary, the blood sample is acquired again.
22. The blood analysis method according to claim 1 or 2, characterized in that: The optical information is obtained based on a first measurement related to the coagulation time measurement, When the information based on the number of platelets in the blood sample is less than a certain value, a second measurement different from the first measurement is performed.
23. The blood analysis method according to claim 1 or 2, characterized in that: The optical information is obtained based on a first measurement related to the coagulation time measurement, When information based on the number of platelets in the blood sample is greater than a certain value, at least one item selected from the group consisting of the following items is executed: not performing a second measurement different from the first measurement, providing information indicating an impact on the second measurement, and providing relevant information regarding the necessity of additional processing of the blood sample before the second measurement.
24. A blood analysis device comprising: a measuring unit that irradiates a mixed solution of a blood sample and a reagent for measuring a coagulation time with light and detects light generated from the mixed solution; A processing unit, which processes the detection result of the measuring unit; The processing unit performs the following operations: After a blood sample and a reagent for measuring a coagulation time are mixed, optical information changing with time is acquired from the mixed solution of the blood sample and the reagent, detecting a coagulation end point from the acquired optical information; acquiring an index value indicating a change in the optical information based on the optical information within a certain time range including a time point after the coagulation end point; Information based on the number of platelets in the blood sample is acquired based on the index value.
25. The blood analysis device according to claim 24, characterized in that: The processing unit acquires information based on the number of platelets in the blood sample based on the optical information on the end stage of the coagulation reaction of the blood sample among the acquired optical information.
26. The blood analysis device according to claim 24 or 25, characterized in that: The information based on the number of platelets in the blood sample includes information related to the number of platelets or the necessity of additional processing of the blood sample.
27. The blood analysis device according to claim 24 or 25, characterized in that: The processing unit acquires the optical information based on a first measurement related to coagulation time measurement, The information based on the platelet count in the blood sample includes information related to the influence on a second measurement different from the first measurement.
28. The blood analysis device according to claim 24, characterized in that: The index value is a change speed or a change amount of the optical information within the certain time range.
29. The blood analysis device according to claim 28, characterized in that: The processing unit acquires the change speed or the change amount based on the optical information at the start point and the end point of the certain time range.
30. The blood analysis device according to claim 24, characterized in that: The processing unit compares the index value with one or more preset first reference values to thereby acquire information on the level of the number of platelets in the blood sample as the information on the number of platelets in the blood sample.
31. The blood analysis device according to claim 24, characterized in that: The processing unit acquires the number of platelets in the blood sample as information based on the number of platelets in the blood sample based on the index value.
32. The blood analysis device according to claim 31, characterized in that: The processing unit acquires the number of platelets in the blood sample from the index value using information indicating a relationship between the index value and the number of platelets.
33. The blood analysis device according to claim 31, characterized in that: The processing unit compares the number of platelets in the blood sample with one or more preset second reference values to further acquire information based on the level of the number of platelets in the blood sample as the information based on the number of platelets in the blood sample.
34. The blood analysis device according to claim 31, characterized in that: The processing unit acquires, as information based on the number of platelets in the blood sample, information indicating the presence of a measurement item affected by platelets in the blood sample or information related to the necessity of additional processing of the blood sample.
35. The blood analysis device according to claim 24 or 25, comprising: Display unit; The processing unit displays information based on the number of platelets in the blood sample on the display unit.
36. The blood analysis device according to claim 24, characterized in that: The processing unit acquires the optical information in the step of measuring the coagulation time of the blood sample.
37. The blood analysis device according to claim 36, characterized in that: The coagulation end point is the end point of a time range for calculating the coagulation time of the blood sample.
38. The blood analysis device according to claim 24, characterized in that: The processing unit sets the starting point of the certain time range to be after the coagulation end point.
39. The blood analysis device according to claim 24, characterized in that: The length of the certain time range is not less than 5 seconds and not more than 10 seconds.
40. The blood analysis device according to claim 24 or 25, characterized in that: The blood sample is plasma.
41. The blood analysis device according to claim 40, characterized in that: The whole blood sample is centrifuged to obtain the plasma.
42. The blood analysis device according to claim 24 or 25, characterized in that: The optical information is the intensity of transmitted light or the intensity of scattered light detected by irradiating the blood sample with light, or absorbance calculated from the intensity of the transmitted light or the intensity of the scattered light.
43. The blood analysis device according to claim 24 or 25, characterized in that: The reagent is a reagent for measuring prothrombin time or a reagent for measuring fibrinogen.
44. The blood analysis device according to claim 24 or 25, characterized in that: The measuring unit includes an irradiating unit for irradiating the mixed liquid with light and a detecting unit for detecting light generated from the mixed liquid. The processing section acquires the optical information based on the detection signal output from the detection section.
45. The blood analysis device according to claim 44, characterized in that: The detection unit detects the light that has passed through the mixed liquid among the light irradiated on the mixed liquid.
46. The blood analysis device according to claim 24 or 25, characterized in that: The processing unit performs the following operations: The optical information is obtained based on a first measurement related to the coagulation time measurement, When the information based on the number of platelets in the blood sample is less than a certain value, a second measurement different from the first measurement is performed.
47. The blood analysis device according to claim 24 or 25, characterized in that: The processing unit performs the following operations: The optical information is obtained based on a first measurement related to the coagulation time measurement, When information based on the number of platelets in the blood sample is greater than a certain value, at least one item selected from the group consisting of the following items is executed: not performing a second measurement different from the first measurement, providing information indicating an impact on the second measurement, and providing relevant information regarding the necessity of additional processing of the blood sample before the second measurement.
48. A storage medium containing an executable program, the program causing a computer to perform the following processing for blood analysis: After a blood sample and a reagent for measuring a coagulation time are mixed, optical information changing with time is obtained from the mixed solution of the blood sample and the reagent. detecting the coagulation end point from the acquired optical information, acquiring an index value indicating a change in the optical information based on the optical information in a certain time range including a time point after the coagulation end point, Information based on the number of platelets in the blood sample is acquired based on the index value.
49. The storage medium containing an executable program according to claim 48, characterized in that: Information based on the number of platelets in the blood sample is acquired based on the optical information on the end stage of the coagulation reaction of the blood sample among the acquired optical information.
50. The storage medium containing an executable program according to claim 48 or 49, characterized in that: The information based on the number of platelets in the blood sample includes information related to the number of platelets or the necessity of additional processing of the blood sample.
51. The storage medium containing an executable program according to claim 48 or 49, characterized in that: The information based on the number of platelets in the blood sample includes information related to the influence on a second measurement, and the second measurement is different from a first measurement related to the coagulation time measurement for obtaining the optical information.
52. The storage medium containing an executable program according to claim 48 or 49, characterized in that: The optical information is obtained based on a first measurement related to the coagulation time measurement, When the information based on the number of platelets in the blood sample is less than a certain value, a second measurement different from the first measurement is performed.
53. The storage medium containing an executable program according to claim 48 or 49, characterized in that: The optical information is obtained based on a first measurement related to the coagulation time measurement, When information based on the platelet count in the blood sample is above a certain value, at least one of the following group selections is performed: not performing a second measurement different from the first measurement, providing information indicating an impact on the second measurement, and providing relevant information regarding the necessity of additional processing of the blood sample before the second measurement.
